Cryopreservation involves the use of very low temperatures for the preservation of cells and tissues. Biomedical warming and thawing devices aid in the warming and thawing of cryopreserved products. Cyropreservative chemicals can damage living cells preserved for a longer duration. Therefore, warming them from the frozen state should take place at a rapid pace till complete thawing is achieved. The frozen cells are rapidly thawed in a water bath at 37°C and then the cells are transferred to pre-warmed growth medium. After thawing, transferring the content of the vials in the medium is important in order to minimize the exposure of cells to cyropreservative agents. Hence, warming and thawing devices are important to reduce the effect of cyropreservatives on the cells, ensuring their viability for use in various purposes in health care and research.
A rise in the number of accident and trauma cases, increase in demand for blood transfusion, and rise in demand for point-of-care thawing device technology are anticipated to drive the global biomedical warming and thawing devices market. Additionally, strategic approaches by market players such as product launches, collaborations, and partnerships are further likely to fuel the growth of the global biomedical warming and thawing devices market during the forecast period. For instance, in December 2018, Pluristem Therapeutics Inc., a regenerative medicine company manufacturing placenta-based cell therapy products, entered into a license agreement with a subsidiary of Chart Industries, Inc. in regards to the company`s thawing device for cell-based therapies. As per the agreement, Chart obtained exclusive rights to develop and market the thawing device worldwide, except in China. In November 2016, Cook and Asymptote, a U.K.-based company, launched water-free automated cell thawing technology. In November 2014, BioCision, a U.S.-based life science research and development company, launched an automated sample thawing system named ThawSTAR to address the need of thawing cells during cryopreservation.
The global biomedical warming and thawing devices market can be segmented based on product, sample, end-user, and region. In terms of product, the global biomedical warming and thawing devices market can be divided into manual and automated devices. The automated devices segment is projected to account for a prominent market share during the forecast period, due to an increase in the demand for automation in life sciences facilities and rise in the number of prominent players offering these devices in the market. Based on sample, the global biomedical warming and thawing devices market can be classified into blood products, ovum/embryo, and semen. In terms of end-user, the global biomedical warming and thawing devices market can be categorized into blood banks & transfusion centers, hospitals, research laboratories, pharmaceutical companies. The blood banks and transfusion centers segment is anticipated to expand at a rapid CAGR during the forecast period, due to an increase in the use of biomedical devices for processing blood and other samples required during transfusion.
Based on region, the global biomedical warming and thawing devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for a prominent market share during the forecast period, due to an increase in the importance of cryopreservation of cells and blood products and the presence of key players manufacturing these devices in the U.S.. The market in Europe is anticipated to expand at a rapid pace during the forecast period, due to a rise in demand for technologically advanced biomedical warming and thawing devices and extensive research activities on blood products in countries such as the U.K., Germany, and France. The biomedical warming and thawing devices market in Asia Pacific is expected to expand at a rapid CAGR during the forecast period, driven by a rise in awareness about cell viability and quality based products for research, increase in the use of biomedical devices, and strengthening of health care infrastructure in emerging markets in Asia Pacific. The biomedical warming and thawing devices market in Middle East & Africa is driven by significant demand for quality care devices and rapid expansion of medical technologies and increase in the use of automated medical systems.
Key players operating in the global biomedical warming and thawing devices market are Helmer Scientific, BioCision, General Electric Company, Sartorius AG, Sarstedt AG & Co. KG, Boekel Scientific, CytoTherm, Cardinal Health, Barkey, and Thermo Fisher Scientific.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
Email: [email protected]